ClinConnect ClinConnect Logo
Search / Trial NCT02653274

Assessment of Millet, Oat and Rye Porridge Breakfasts Glucose and Gastric Emptying

Launched by UNIVERSITY OF NOTTINGHAM · Jan 11, 2016

Trial Information

Current as of May 30, 2025

Completed

Keywords

Mri Blood Glucose Satiety Breakfast Porridge Grains

ClinConnect Summary

Background: Porridge breakfasts from various grains are a staple source of energy for many populations worldwide. The grains used in the porridges differ between regions, mostly due to the crops historically grown. For example, oats are more common in the Anglo-Saxon countries; rye is traditional in the Scandinavian countries whilst millet is very common in parts of India and Africa. Porridge consumption is very popular: 78% of South Africans eat porridge; 49% of British people eat porridge with 23% doing so almost daily; 62% of U.S. households buy hot cereal breakfast and the hot cereal se...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 18-65
  • Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2
  • Able to give informed consent
  • Apparently healthy: no medical conditions which might affect study measurements (judged by study physician)
  • Exclusion Criteria:
  • Use of medication which interferes with study measurements (as judged by the study physician).
  • Participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study.
  • Not used to eating breakfast
  • Not used to eating three meals a day
  • Reported participation in night shift work during the two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM.
  • Strenuous exercise for more than10 hours per week.
  • Consumption of ≥21 alcoholic drinks in a typical week
  • Reported weight loss or gain ≥ 10 % of bodyweight during the six months period before the pre-study examination.
  • Following a medically- or self-prescribed diet during the two weeks prior to the pre-study examination and until the end of the study
  • Dislike of the products served as the dietary test treatments
  • Any allergy or food intolerance to the test treatments
  • An eating disorder as indicated by the Three factor eating questionnaire
  • Not suitable for MRI scanning (e.g., presence of metal implants, infusion pumps and pacemakers) as assessed by standard MRI safety questionnaire.
  • Pregnancy declared by candidate
  • Antibiotic or prescribed probiotic treatment in the past 12 weeks
  • Inability to lie flat
  • Exceeding the scanner bed weight limit of120kg
  • Poor understanding of the spoken and/or written English language

About University Of Nottingham

The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.

Locations

Nottingham, Nottinghamshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Jaber Alyami, MRes

Study Director

Nottingham Digestive Diseases Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials